Pulsar Medtech

Wearable Bone Growth Stimulators

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in June 2021, Pulsar Medtech operates with 1–10 employees. In June 2024, Pulsar Medtech received seed funding from Iron Nation.

Business overview

Pulsar Medtech is transforming bone growth stimulator (BGS) technology into wearable devices to improve patient outcomes and comfort. The company's core product is the Fracture Healing Patch (FHP), a smart, wearable BGS device designed to replace bulky traditional devices. This innovative patch aims to heal non-union fractures and accelerate the healing of common fractures by up to 30%. Pulsar Medtech serves the orthopedic market, focusing on patients and healthcare providers within the Medical Devices and Healthcare & Life Sciences sectors, with a primary market in North America.

Company Intelligence Q&A

What is Pulsar Medtech's primary product?
Pulsar Medtech's flagship product is the Fracture Healing Patch (FHP), a smart, wearable bone growth stimulator designed to accelerate bone healing and treat non-union fractures.
When was Pulsar Medtech founded?
Pulsar Medtech was founded in June 2021.
What is the company's employee count?
Pulsar Medtech currently has 1–10 employees.
What is Pulsar Medtech's mission?
Pulsar Medtech's mission is to revolutionize the orthopedic world by transforming bone growth stimulator technology into wearable devices, aiming to improve patient outcomes and comfort.
What is the company's product stage?
Pulsar Medtech's product, the Fracture Healing Patch (FHP), is currently in the R&D stage. The company aims to replace traditional, bulky BGS devices with this smart, wearable electronic patch.